1122533

Aziz I. Shaibani, M.D. — FEI 3006648734

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 28, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)